Merus N.V.
Latest round
- Series C
Last raised
- Aug 2015
Total raised
- $155M
Investors
- 10
About Merus N.V.
V. operates as a biotechnology company that develops the Multiclonics platform used to screen and generate molecular and cell-based bispecific antibody therapeutics. In May 2016, the company was listed on the Nasdaq for an IPO (Initial Public Offering) under the ticker symbol MRUS.V.82 million shares at USD 22 on the Nasdaq Global Market. The company's R&D team offers IgG antibody therapeutics through the Multiclonics platform that discovers and screens bi-specific and tri-specific antibodies capable of binding two or more targets for the treatment of patients with cancer, as well as infectious and inflammatory diseases. Merus is also working on clinical trials for drug candidates, namely MCLA-128, MCLA-129, MCLA-158, MCLA-145, and ONO-4685.V. generates revenue by collaborating with pharmaceutical and biotechnology companies and academic institutions to extend its platform and product candidates' reach and capabilities.
Who invested in Merus N.V.
10 investors across 4 rounds
See all investors in Merus N.V.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Merus N.V.
Who invested in Merus N.V.?
Merus N.V. has 10 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Merus N.V. raised?
Merus N.V. has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Merus N.V. last raise money?
Merus N.V.'s most recent round on record is a Series C, in Aug 2015.
What does Merus N.V. do?
Merus N.V. is a biotechnology company.
Where is Merus N.V. headquartered?
Merus N.V. is headquartered in Utrecht, Netherlands.
Which VCs invest in companies like Merus N.V.?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Merus N.V.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Merus N.V.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.